MAHLY
Price
$16.01
Change
+$0.96 (+6.38%)
Updated
Jun 27 closing price
Capitalization
3.69B
SHPMF
Price
$1.56
Change
-$0.01 (-0.64%)
Updated
Mar 17 closing price
Capitalization
9.5B
Interact to see
Advertisement

MAHLY vs SHPMF

Header iconMAHLY vs SHPMF Comparison
Open Charts MAHLY vs SHPMFBanner chart's image
Medipal Holdings
Price$16.01
Change+$0.96 (+6.38%)
Volume$3.04K
Capitalization3.69B
Shanghai Pharmaceuticals Holdings
Price$1.56
Change-$0.01 (-0.64%)
Volume$500
Capitalization9.5B
MAHLY vs SHPMF Comparison Chart in %
Loading...
MAHLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MAHLY vs. SHPMF commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MAHLY is a Buy and SHPMF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (MAHLY: $16.01 vs. SHPMF: $1.56)
Brand notoriety: MAHLY and SHPMF are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: MAHLY: 139% vs. SHPMF: 100%
Market capitalization -- MAHLY: $3.69B vs. SHPMF: $9.5B
MAHLY [@Medical Distributors] is valued at $3.69B. SHPMF’s [@Medical Distributors] market capitalization is $9.5B. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MAHLY’s FA Score shows that 0 FA rating(s) are green whileSHPMF’s FA Score has 0 green FA rating(s).

  • MAHLY’s FA Score: 0 green, 5 red.
  • SHPMF’s FA Score: 0 green, 5 red.
According to our system of comparison, both MAHLY and SHPMF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MAHLY’s TA Score shows that 2 TA indicator(s) are bullish.

  • MAHLY’s TA Score: 2 bullish, 5 bearish.

Price Growth

MAHLY (@Medical Distributors) experienced а +6.38% price change this week, while SHPMF (@Medical Distributors) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +2.01%. For the same industry, the average monthly price growth was +7.79%, and the average quarterly price growth was -2.46%.

Industries' Descriptions

@Medical Distributors (+2.01% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SHPMF($9.5B) has a higher market cap than MAHLY($3.69B). MAHLY has higher P/E ratio than SHPMF: MAHLY (13.48) vs SHPMF (8.28). MAHLY YTD gains are higher at: -0.404 vs. SHPMF (-4.732). MAHLY has higher annual earnings (EBITDA): 74B vs. SHPMF (11.1B). MAHLY has more cash in the bank: 252B vs. SHPMF (38.1B). MAHLY has less debt than SHPMF: MAHLY (30B) vs SHPMF (44.4B). MAHLY has higher revenues than SHPMF: MAHLY (3.35T) vs SHPMF (241B).
MAHLYSHPMFMAHLY / SHPMF
Capitalization3.69B9.5B39%
EBITDA74B11.1B667%
Gain YTD-0.404-4.7329%
P/E Ratio13.488.28163%
Revenue3.35T241B1,390%
Total Cash252B38.1B661%
Total Debt30B44.4B68%
FUNDAMENTALS RATINGS
MAHLY vs SHPMF: Fundamental Ratings
MAHLY
SHPMF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
50
Fair valued
PROFIT vs RISK RATING
1..100
10093
SMR RATING
1..100
4180
PRICE GROWTH RATING
1..100
5458
P/E GROWTH RATING
1..100
6265
SEASONALITY SCORE
1..100
65n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SHPMF's Valuation (50) in the null industry is somewhat better than the same rating for MAHLY (86). This means that SHPMF’s stock grew somewhat faster than MAHLY’s over the last 12 months.

SHPMF's Profit vs Risk Rating (93) in the null industry is in the same range as MAHLY (100). This means that SHPMF’s stock grew similarly to MAHLY’s over the last 12 months.

MAHLY's SMR Rating (41) in the null industry is somewhat better than the same rating for SHPMF (80). This means that MAHLY’s stock grew somewhat faster than SHPMF’s over the last 12 months.

MAHLY's Price Growth Rating (54) in the null industry is in the same range as SHPMF (58). This means that MAHLY’s stock grew similarly to SHPMF’s over the last 12 months.

MAHLY's P/E Growth Rating (62) in the null industry is in the same range as SHPMF (65). This means that MAHLY’s stock grew similarly to SHPMF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MAHLYSHPMF
RSI
ODDS (%)
Bearish Trend 4 days ago
55%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
43%
N/A
Momentum
ODDS (%)
Bearish Trend 4 days ago
43%
N/A
MACD
ODDS (%)
Bullish Trend 4 days ago
24%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
34%
Bullish Trend 4 days ago
41%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
33%
Bullish Trend 4 days ago
35%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
40%
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
35%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
MAHLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
GNS.X1.6189690.099874
+6.57%
Gains Network cryptocurrency
FIS.X0.0790710.003921
+5.22%
StaFi cryptocurrency
LUNA.X0.1499070.003269
+2.23%
Terra cryptocurrency
PENDLE.X3.3472710.012411
+0.37%
Pendle cryptocurrency
MFT.X0.001722N/A
N/A
Mainframe cryptocurrency

MAHLY and

Correlation & Price change

A.I.dvisor tells us that MAHLY and MEPDF have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MAHLY and MEPDF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MAHLY
1D Price
Change %
MAHLY100%
N/A
MEPDF - MAHLY
9%
Poorly correlated
N/A
ZYXI - MAHLY
5%
Poorly correlated
-10.78%
ARRJF - MAHLY
2%
Poorly correlated
N/A
SHPMF - MAHLY
2%
Poorly correlated
N/A
NSVGF - MAHLY
2%
Poorly correlated
N/A
More

SHPMF and

Correlation & Price change

A.I.dvisor tells us that SHPMF and MEPDF have been poorly correlated (+2% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SHPMF and MEPDF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHPMF
1D Price
Change %
SHPMF100%
N/A
MEPDF - SHPMF
2%
Poorly correlated
N/A
MAHLY - SHPMF
2%
Poorly correlated
N/A
PDRX - SHPMF
1%
Poorly correlated
N/A
ZYXI - SHPMF
1%
Poorly correlated
-10.78%
AMFPF - SHPMF
-0%
Poorly correlated
N/A
More